Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Changchun BCHT Biotechnology C (688276 CH)
Watchlist
42
Analysis
Health Care
•
China
Changchun BCHT Biotechnology Co. Ltd. operates as a high-tech biopharmaceutical company. The Company provides human vaccine researching, development, production, and sales services. Changchun BCHT Biotechnology markets its products throughout China.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Piotech
•
28 Aug 2023 05:09
STAR50 Index Rebalance: Two Changes; Pre-Positioning Appears Light
There are 2 changes for the STAR50 in Sep. The adds/dels were expected and there has been big outperformance over the last few weeks. But,...
Brian Freitas
Follow
814 Views
Share
bullish
•
Piotech
•
25 Aug 2023 07:33
STAR50 Index Rebalance Preview: Potential Changes Playing Catchup
Changes will be announced after market close today. The potential adds have outperformed the potential deletes by over 10% since the end of the...
Brian Freitas
Follow
1k Views
Share
bullish
•
Eoptolink Technology
•
04 Jul 2023 05:40
CSI500 Index Rebalance Preview: Potential Adds Outperforming Potential Deletes
We see 50 changes a side for the CSI500 in Dec. The Industrials sector could take a lot of index spots from Materials as one-way turnover exceeds...
Brian Freitas
Follow
755 Views
Share
bullish
•
Piotech
•
15 Jun 2023 06:20
STAR50 Index Rebalance Preview: One High Probability Change; One 'It Depends'
There could be 2 changes in September if a 6 month minimum listing history is used. Piotech was added to the CSI500 in June and there are multiple...
Brian Freitas
Follow
738 Views
Share
bullish
•
AVIC (Chengdu) UAS Co Ltd
•
27 May 2023 12:21
STAR50 Index Rebalance: Two Changes in June (As Expected)
There are 2 changes for the STAR50 Index as a 6-month minimum listing history is used. There is little increase in excess volume on the adds while...
Brian Freitas
Follow
841 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x